RAPT Therapeutics Inc (RAPT)
8.33
+0.20
(+2.52%)
USD |
NASDAQ |
May 03, 16:00
8.33
0.00 (0.00%)
After-Hours: 20:00
RAPT Therapeutics Free Cash Flow: -98.17M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -98.17M |
| September 30, 2023 | -93.25M |
| June 30, 2023 | -88.53M |
| March 31, 2023 | -75.25M |
| December 31, 2022 | -71.62M |
| September 30, 2022 | -69.79M |
| June 30, 2022 | -65.15M |
| March 31, 2022 | -63.37M |
| December 31, 2021 | -61.78M |
| September 30, 2021 | -56.25M |
| June 30, 2021 | -53.74M |
| Date | Value |
|---|---|
| March 31, 2021 | -46.18M |
| December 31, 2020 | -40.89M |
| September 30, 2020 | -31.06M |
| June 30, 2020 | -33.20M |
| March 31, 2020 | -36.15M |
| December 31, 2019 | -36.36M |
| September 30, 2019 | -41.51M |
| June 30, 2019 | -38.96M |
| March 31, 2019 | -37.45M |
| December 31, 2018 | -36.45M |
Free Cash Flow Range, Past 5 Years
-98.17M
Minimum
Dec 2023
-31.06M
Maximum
Sep 2020
-57.96M
Average
-56.25M
Median
Sep 2021
Free Cash Flow Benchmarks
| Emergent BioSolutions Inc | -257.90M |
| Avinger Inc | -14.44M |
| Tonix Pharmaceuticals Holding Corp | -109.90M |
| Skye Bioscience Inc | -13.96M |
| Axsome Therapeutics Inc | -145.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.75M |
| Cash from Investing (Quarterly) | 20.64M |
| Cash from Financing (Quarterly) | 0.458M |
| Free Cash Flow Per Share (Quarterly) | -0.7248 |
| Free Cash Flow Yield | -30.74% |